Back

Choose your region

Summary
patients treated

Has anyone ever benefited from stem cell?

For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.

FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.

List of patients

List of patients
No. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
501 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 4
502 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 31
503 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 49
504 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 8
505 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 15
506 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 17
507 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 81
508 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 29
509 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 15
510 Bone Marrow Allogeneic Severe Combined Immunodeficiency Hematology 2023 Standard Therapy Poland 1
511 Bone Marrow Allogeneic Sickle Cell Disease Hematology 2023 Standard Therapy Poland 5
512 Bone Marrow Allogeneic T-Acute Lymphoblastic Leukemia, Ataxia Telangiectasia Hematology 2023 Standard Therapy Poland 8
513 Bone Marrow Allogeneic T-Cell Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 16
514 Bone Marrow Allogeneic Thalassemia Major Hematology 2023 Standard Therapy Poland 2
515 Bone Marrow Allogeneic Very Severe Aplastic Anemia Hematology 2023 Standard Therapy Poland 21
516 Bone Marrow Allogeneic Wiskott-Aldrich Syndrome Hematology 2023 Standard Therapy Poland 1
517 Bone Marrow Allogeneic Wiskott-Aldrich Syndrome Hematology 2023 Standard Therapy Poland 3
518 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Germany 67
519 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 37
520 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 47
521 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 16
522 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 58
523 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 64
524 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 66
525 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 11
526 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 8
527 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 52
528 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 51
529 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Germany 54
530 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 54
531 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 40
532 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Germany 60
533 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Germany 40
534 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 51
535 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 35
536 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 65
537 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 47
538 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Germany 39
539 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 54
540 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 37
541 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 54
542 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 19
543 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 20
544 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 37
545 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 42
546 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 48
547 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Germany 47
548 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Germany 64
549 Apheresis Autologous Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Germany 61
550 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 20
551 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 65
552 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 40
553 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 57
554 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 44
555 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 54
556 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Germany 31
557 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 30
558 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2023 Standard Therapy Poland 60
559 Apheresis Allogeneic Acute Lymphoblastic Leukemia T-Cell; Myelodysplastic Syndrome" Hematology 2023 Standard Therapy Poland 72
560 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Germany 58
561 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Germany 60
562 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 32
563 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 28
564 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 50
565 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 70
566 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 50
567 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 64
568 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 63
569 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 41
570 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 57
571 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 63
572 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 38
573 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 57
574 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 57
575 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 67
576 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 87
577 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 71
578 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 60
579 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 47
580 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 46
581 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 56
582 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 46
583 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 33
584 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 53
585 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 55
586 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 69
587 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 38
588 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 57
589 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 1
590 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 28
591 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 55
592 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 60
593 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 62
594 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 60
595 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 31
596 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 67
597 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 73
598 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 82
599 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 73
600 Apheresis Allogeneic Acute Myeloid Leukemia Hematology 2023 Standard Therapy Poland 55